The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes.
AUTOR(ES)
Zhu, L
RESUMO
Unregulated expression of either the retinoblastoma protein (pRB) or the related protein p107 can cause growth arrest of sensitive cells in the G1 phase of the cell cycle. However, growth arrests mediated by p107 and pRB are not identical. Through structure-function and co-expression analyses we have dissected the p107 molecule into two domains that independently are able to block cell cycle progression. One domain corresponds to the sequences needed for interaction with the transcription factor E2F, and the other corresponds to the interaction domain for cyclin A or cyclin E complexes. In cervical carcinoma cell line C33A, which was previously shown to be sensitive to p107 but resistant to pRB growth suppression, only the cyclin binding domain is active as a growth suppressor. Furthermore, we show that these two independent domains are functional in untransformed mouse fibroblasts. Together, these results provide experimental evidence for the presence of two functional domains in p107 and pinpoint an important functional difference between p107 and pRB.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=398289Documentos Relacionados
- The Rb-related p107 protein can suppress E2F function independently of binding to cyclin A/cdk2.
- Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation.
- G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes.
- Interactions of the p107 and Rb proteins with E2F during the cell proliferation response.
- Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen.